Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
fda
life sciences
national blog main
amgen
europe blog main
national
abaloparatide
abbvie
allergan
bempedoic acid
bial
biohaven
cgpr
cholesterol
corticosteroids
detroit
detroit blog main
detroit top stories
drug development
eli lilly
esperion therapeutics
europe top stories
european commission
ezetimibe
fluoroquinolones
merck
migraine
national top stories
neurocrine
neurodegeneration
neuroscience
new york blog main
opicapone
osteoporosis
parkinson's disease
radius health
romosozumab
san diego
What
nod
4
×
fda
pill
wins
approved
drug
medicines
add
adults
allergan
amgen
amgen’s
approval
called
carbidopa
carries
cholesterol
class
combination
combo
control
daily
developed
disease
esperion
esperion’s
europe
european
experience
gets
heart
levels
levodopa
lowering
marketing
medication
medicine
migraine
monday
neurocrine
Language
unset
4
×
Current search:
nod
×
unset
×
@xconomy.com
3 years ago
Neurocrine Gets FDA Nod for Once-Daily “Add-On” Parkinson’s Pill
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning